CD19-targeted 19-28z CAR modified autologous T cells induce high rates of complete remission and durable responses in adult patients with relapsed, refractory B-cell ALL Meeting Abstract

  

Authors:	Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y. J.; Yoo, S.; Purdon, T.; Halton, E.; Quintanilla, H.; Curran, K. J.; Sauter, C. S.; Davila, M. L.; Sadelain, M.; Brentjens, R. J.
Abstract Title:	CD19-targeted 19-28z CAR modified autologous T cells induce high rates of complete remission and durable responses in adult patients with relapsed, refractory B-cell ALL
Meeting Title:	56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	124
Issue:	21
Meeting Dates:	2014 Dec 6-9
Meeting Location:	San Francisco, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2014-12-06
Language:	English
ACCESSION:	WOS:000349243503034
PROVIDER:	wos
DOI:	10.1182/blood.V124.21.382.382
Notes:	Meeting Abstract: 382 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/71537